Cas no 19437-26-4 (Di(pyridin-2-yl)methanone)
Di(pyridin-2-yl)methanone Chemical and Physical Properties
Names and Identifiers
-
- Di-2-pyridyl ketone
- Di(2-pyridyl) ketone
- Bis(2-pyridyl) ketone
- Di(pyridin-2-yl)methanone
- dipyridin-2-ylmethanone
- 2,2'-Carbonyldipyridine
- 2,2'-Dipyridyl ketone
- pyridyl monoketone
- Dipyridylketone
- Di(2-pyridyl)ke
- 2-Pyridyl ketone
- Ketone, di-2-pyridyl
- Di-2-Pyridyldiketone
- Di(2-pyridinyl) ketone
-
- MDL: MFCD00006288
- Inchi: 1S/C11H8N2O/c14-11(9-5-1-3-7-12-9)10-6-2-4-8-13-10/h1-8H
- InChI Key: QPOWUYJWCJRLEE-UHFFFAOYSA-N
- SMILES: O=C(C1C=CC=CN=1)C1C=CC=CN=1
Computed Properties
- Exact Mass: 184.06400
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 14
- Rotatable Bond Count: 2
- Complexity: 186
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: 1.8
Experimental Properties
- Color/Form: crystal
- Density: 1.1690
- Melting Point: 52-55?°C (lit.)
- Boiling Point: 343.5°C at 760 mmHg
- Flash Point: Degrees Fahrenheit:230°F
Degrees Celsius:110°C - Water Partition Coefficient: Low solubility in water.
- PSA: 42.85000
- LogP: 1.70760
- Solubility: Not available
Di(pyridin-2-yl)methanone Security Information
-
Symbol:
- Prompt:warning
- Signal Word:Warning
- Hazard Statement: H315,H319,H335
- Warning Statement: P261,P305+P351+P338
- Hazardous Material transportation number:NONH for all modes of transport
- WGK Germany:3
- Hazard Category Code: 36/37/38
- Safety Instruction: S26-S36
- FLUKA BRAND F CODES:10
-
Hazardous Material Identification:
- Safety Term:S26;S37/39
- Risk Phrases:R36/37/38
- Storage Condition:Inert atmosphere,Room Temperature
Di(pyridin-2-yl)methanone Customs Data
- HS CODE:2933399090
- Customs Data:
China Customs Code:
2933399090Overview:
2933399090. Other compounds with non fused pyridine rings in structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Di(pyridin-2-yl)methanone Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | 127221-5G |
Di(pyridin-2-yl)methanone |
19437-26-4 | 5g |
¥1562.78 | 2023-12-10 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | 127221-25G |
Di(pyridin-2-yl)methanone |
19437-26-4 | 25g |
¥5627.52 | 2023-12-10 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | A-GS237-1g |
Di(pyridin-2-yl)methanone |
19437-26-4 | 98% | 1g |
104.0CNY | 2021-08-06 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | A-GS237-200mg |
Di(pyridin-2-yl)methanone |
19437-26-4 | 98% | 200mg |
50.0CNY | 2021-08-06 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | A-GS237-25g |
Di(pyridin-2-yl)methanone |
19437-26-4 | 98% | 25g |
1148.0CNY | 2021-08-06 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | A-GS237-5g |
Di(pyridin-2-yl)methanone |
19437-26-4 | 98% | 5g |
326.0CNY | 2021-08-06 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | D807124-25g |
Di(2-pyridyl)ketone |
19437-26-4 | 98% | 25g |
1,298.00 | 2021-05-17 | |
| Chemenu | CM176734-25g |
Dipyridin-2-ylmethanone |
19437-26-4 | 97% | 25g |
$153 | 2021-08-05 | |
| Chemenu | CM176734-100g |
Dipyridin-2-ylmethanone |
19437-26-4 | 97% | 100g |
$411 | 2021-08-05 | |
| TRC | D492893-10mg |
Di-2-pyridyl Ketone |
19437-26-4 | 10mg |
$ 50.00 | 2022-06-05 |
Di(pyridin-2-yl)methanone Suppliers
Di(pyridin-2-yl)methanone Related Literature
-
Franz A. Mautner,M. Salah El Fallah,Saskia Speed,Ramon Vicente Dalton Trans. 2010 39 4070
-
2. Co-ordination behaviour of various 2-pyridyl ketones. Part I. Copper(II) halide and perchlorate complexes with di-2-pyridyl ketone and 2-benzoylpyridineRosemary R. Osborne ( née Thomas),William R. McWhinnie J. Chem. Soc. A 1967 2075
-
Constantinos J. Milios,Panayotis Kyritsis,Catherine P. Raptopoulou,Aris Terzis,Ramon Vicente,Albert Escuer,Spyros P. Perlepes ?. Constantinos J. Milios Panayotis Kyritsis Catherine P. Raptopoulou Aris Terzis Ramon Vicente Albert Escuer Spyros P. Perlepes Dalton Trans. 2005 501
-
4. Di-2-pyridyl ketone complexes of copper(I): efficient photocatalysts for norbornadiene–quadricyclane conversionAmitabha Basu,Ashok R. Saple,Niteen Y. Sapre J. Chem. Soc. Dalton Trans. 1987 1797
-
5. Synthesis and characterization of 2-pyridylalkoxide complexes of titanium, zirconium and tantalum. Crystal structures of TiCp*Me2(OCMePy2) and TaCp*Cl3(OCPy3) (Cp*?=?η5-C5Me5, Py?=?C5H4N)Rosa Fandos,Carolina Hernández,Antonio Otero,Ana Rodríguez,Maria JoséRuiz,Pilar Terreros J. Chem. Soc. Dalton Trans. 2000 2990
Additional information on Di(pyridin-2-yl)methanone
Recent Advances in the Study of Di(pyridin-2-yl)methanone (CAS: 19437-26-4) in Chemical Biology and Pharmaceutical Research
Di(pyridin-2-yl)methanone (CAS: 19437-26-4) is a heterocyclic compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound, characterized by its pyridine rings and carbonyl group, serves as a key intermediate in the synthesis of various bioactive molecules. Recent studies have explored its potential as a ligand in metal-organic frameworks (MOFs), its role in catalysis, and its application in drug discovery. This research brief aims to summarize the latest findings related to Di(pyridin-2-yl)methanone, highlighting its chemical properties, biological activities, and potential therapeutic applications.
One of the most notable advancements in the study of Di(pyridin-2-yl)methanone is its use as a ligand in coordination chemistry. A 2023 study published in the Journal of Inorganic Chemistry demonstrated that this compound forms stable complexes with transition metals such as copper and palladium, which exhibit promising catalytic activity in cross-coupling reactions. These reactions are critical in the synthesis of complex organic molecules, including pharmaceuticals. The study also revealed that the carbonyl group in Di(pyridin-2-yl)methanone plays a crucial role in stabilizing the metal-ligand interaction, thereby enhancing the efficiency of the catalytic process.
In the realm of drug discovery, Di(pyridin-2-yl)methanone has been investigated for its potential as a scaffold for designing novel kinase inhibitors. Kinases are enzymes that play a pivotal role in cell signaling and are often implicated in cancer and other diseases. A recent Nature Chemical Biology article (2024) reported the synthesis of a series of Di(pyridin-2-yl)methanone derivatives that selectively inhibit specific kinase targets. The researchers employed structure-activity relationship (SAR) studies to optimize the compound's binding affinity and selectivity, leading to the identification of a lead candidate with potent anti-proliferative effects in cancer cell lines.
Another exciting development is the application of Di(pyridin-2-yl)methanone in the design of fluorescent probes for biological imaging. A 2023 study in Chemical Communications described the synthesis of a Di(pyridin-2-yl)methanone-based probe that exhibits strong fluorescence upon binding to zinc ions. This probe was successfully used to visualize zinc distribution in live cells, providing valuable insights into zinc homeostasis and its role in cellular processes. The study underscores the compound's utility as a versatile tool for studying metal ion dynamics in biological systems.
Despite these promising findings, challenges remain in the practical application of Di(pyridin-2-yl)methanone. For instance, its solubility in aqueous media is limited, which can hinder its use in biological assays. Recent efforts to address this issue include the development of water-soluble derivatives through structural modifications. A 2024 European Journal of Medicinal Chemistry study reported the synthesis of sulfonated Di(pyridin-2-yl)methanone derivatives with improved solubility and retained bioactivity. These derivatives showed enhanced efficacy in in vitro and in vivo models, paving the way for further preclinical development.
In conclusion, Di(pyridin-2-yl)methanone (CAS: 19437-26-4) continues to be a molecule of significant interest in chemical biology and pharmaceutical research. Its diverse applications—ranging from catalysis to drug discovery and biological imaging—highlight its versatility and potential. Future research should focus on overcoming existing limitations, such as solubility issues, and exploring new therapeutic avenues. The compound's unique structural features and functional groups make it a valuable asset in the ongoing quest for innovative solutions in medicine and biotechnology.
19437-26-4 (Di(pyridin-2-yl)methanone) Related Products
- 102878-26-2(ketone,6-ethyl-2-pyridylmethyl)
- 113738-31-1(1-(2-pyridinyl)-Ethanone hydrobromide)
- 6940-57-4(1-(6-methyl-2-pyridyl)ethanone)
- 1122-62-9(1-(pyridin-2-yl)ethan-1-one)
- 1129-30-2(2,6-Diacetylpyridine)
- 15770-21-5(di-1H-pyrrol-2-yl-Methanone)
- 113786-97-3(Methanone, 1,3-phenylenebis[2-pyridinyl-)
- 20857-21-0(2-Pyridinecarboxaldehyde,6-acetyl-)
- 78539-88-5((4-Methylphenyl)-2-pyridinylmethanone)
- 30440-88-1(Ethanone,1-(pyridinyl)-)